| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 11022510 | Molecular Metabolism | 2018 | 10 Pages |
Abstract
These results provided pre-clinical evidence that PLA2G1B inhibition in the digestive tract may be a viable alternative option to bariatric surgery for obesity and obesity-related cardiometabolic disorder intervention.
Keywords
Related Topics
Life Sciences
Neuroscience
Endocrine and Autonomic Systems
Authors
James G. Cash, Eddy Konaniah, Narasimha Hegde, David G. Kuhel, Miki Watanabe, Lindsey Romick-Rosendale, David Y. Hui,